Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s12282-025-01695-6
Published Online: 2025-03-27
Published Print: 2025-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toi, Masakazu
Text and Data Mining valid from 2025-03-27
Version of Record valid from 2025-03-27
Article History
Received: 16 March 2025
Accepted: 16 March 2025
First Online: 27 March 2025
Free to read: This content has been made available to all.